This Bill Gates-backed coronavirus vaccine developer has skyrocketed 431% in just 2 days after going public (CVAC)

This Bill Gates-backed coronavirus vaccine developer has skyrocketed 431% in just 2 days after going public (CVAC)

Business Insider

Published

**

· *CureVac, a German biotechnology company, skyrocketed in its initial public offering on Friday, raising $213.3 million and more than tripling from its IPO price. *
· *Shares of the company have continued to surge since its Friday IPO, gaining as much as 52% to $85 per share on Monday —** a 431% jump from the...

Full Article